Loading viewer...
conference
Format: PDF conference
Emeco Holdings presented an operational and trading update at the Canaccord Conference in Perth, detailing strong half-on-half earnings growth driven by equipment and services demand. The company narrowed FY23 Operating EBITDA guidance to $248-252 million, with expectations of net leverage at target 1x ratio. Focus areas include expanding fully maintained projects, improving margins through repricing and cost management, and leveraging its unique midlife rebuild model to maintain competitive advantage.
conference
14 Pages
US Biostimulant Coalition & BPI
Mallinckrodt Pharmaceuticals 2016 Jefferies London Healthcare Conference
conferenceconference
15 Pages
Mallinckrodt Pharmaceuticals